Driehaus Capital Management LLC Apellis Pharmaceuticals, Inc. Transaction History

Driehaus Capital Management LLC

$9.27 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$55.39 - $72.47 $1.19 Million - $1.56 Million	21,538 Added 4.47%	503,039 $29.6 Million
Q4 2023 Feb 14, 2024	BUY	$37.14 - $64.82 $11.1 Million - $19.5 Million	300,177 Added 165.55%	481,501 $28.8 Million
Q3 2023 Nov 14, 2023	SELL	$23.65 - $89.22 $3.93 Million - $14.8 Million	-166,052 Reduced 47.8%	181,324 $6.9 Million
Q2 2023 Aug 14, 2023	BUY	$76.68 - $93.31 $5.88 Million - $7.16 Million	76,683 Added 28.33%	347,376 $31.6 Million
Q1 2023 May 15, 2023	SELL	$46.59 - $66.96 $1.06 Million - $1.53 Million	-22,852 Reduced 7.78%	270,693 $17.9 Million
Q4 2022 Feb 14, 2023	SELL	$43.24 - $61.04 $24.4 Million - $34.5 Million	-564,586 Reduced 65.79%	293,545 $15.2 Million
Q3 2022 Nov 14, 2022	BUY	$44.76 - $69.66 $4.39 Million - $6.83 Million	97,982 Added 12.89%	858,131 $58.6 Million
Q2 2022 Aug 15, 2022	BUY	$35.07 - $59.21 $4.61 Million - $7.79 Million	131,504 Added 20.92%	760,149 $34.4 Million
Q1 2022 May 16, 2022	BUY	$35.46 - $54.12 $13 Million - $19.8 Million	365,748 Added 139.12%	628,645 $31.9 Million
Q4 2021 Feb 14, 2022	SELL	$30.74 - $49.16 $389,014 - $622,119	-12,655 Reduced 4.59%	262,897 $12.4 Million
Q3 2021 Nov 15, 2021	BUY	$31.4 - $69.84 $507,392 - $1.13 Million	16,159 Added 6.23%	275,552 $9.08 Million
Q2 2021 Aug 16, 2021	SELL	$40.9 - $64.9 $173,743 - $275,695	-4,248 Reduced 1.61%	259,393 $16.4 Million
Q1 2021 May 17, 2021	SELL	$40.8 - $57.39 $5.15 Million - $7.25 Million	-126,310 Reduced 32.39%	263,641 $11.3 Million
Q4 2020 Feb 16, 2021	BUY	$30.79 - $57.2 $58,932 - $109,480	1,914 Added 0.49%	389,951 $22.3 Million
Q3 2020 Nov 16, 2020	SELL	$25.89 - $33.65 $977,451 - $1.27 Million	-37,754 Reduced 8.87%	388,037 $11.7 Million
Q2 2020 Aug 14, 2020	SELL	$24.8 - $38.49 $2.15 Million - $3.34 Million	-86,679 Reduced 16.91%	425,791 $13.9 Million
Q1 2020 May 15, 2020	BUY	$17.91 - $44.33 $999,485 - $2.47 Million	55,806 Added 12.22%	512,470 $13.7 Million
Q4 2019 Feb 12, 2020	BUY	$22.1 - $30.8 $6.99 Million - $9.74 Million	316,320 Added 225.39%	456,664 $14 Million
Q3 2019 Nov 14, 2019	BUY	$24.09 - $32.18 $3.38 Million - $4.52 Million	140,344 New	140,344 $3.38 Million

Others Institutions Holding APLS

# of Institutions

300

Shares Held

113M

Call Options Held

5.21M

Put Options Held

691K

Wellington Management Group LLP Boston, MA

16.4M
Shares

$460 Million
0.11% of portfolio
Eco R1 Capital, LLC San Francisco, CA

11.6M
Shares

$326 Million
15.74% of portfolio
Avoro Capital Advisors LLC New York, NY

11.1M
Shares

$312 Million
5.82% of portfolio
Vanguard Group Inc Valley Forge, PA

9.81M
Shares

$275 Million
0.01% of portfolio
Black Rock Inc. New York, NY

5.8M
Shares

$163 Million
0.01% of portfolio

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.08B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.

Account